A volatile biomarker in breath predicts lung cancer and pulmonary nodules

被引:39
|
作者
Phillips, Michael [1 ,2 ]
Bauer, Thomas L. [3 ,4 ]
Pass, Harvey, I [5 ]
机构
[1] Menssana Res Inc, 1 Horizon Rd,Suite 1415, Ft Lee, NJ 07024 USA
[2] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[3] Christiana Care Hlth Syst, Newark, DE USA
[4] 19 Davis Ave, Neptune City, NJ 07753 USA
[5] NYU, Langone Med Ctr, 550 1St Ave, New York, NY USA
关键词
breath; volatile organic compounds; biomarker; pulmonary nodules; CORONARY-ANGIOGRAPHY; ORGANIC-COMPOUNDS; OXIDATIVE STRESS; PROBABILITY; PRETEST; AIR;
D O I
10.1088/1752-7163/ab21aa
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: previous studies have reported volatile organic compounds (VOCs) in the breath as apparent biomarkers of lung cancer. We tested the hypothesis that a robust breath VOC biomarker of lung cancer should also predict pulmonary nodules in chest CT images. Methods: Biomarker discovery study (unblinded): 301 subjects were screened for lung cancer with low dose chest CT (LDCT), and donated duplicate samples of alveolar breath for analysis with gas chromatography mass spectrometry (GC MS). Monte Carlo analysis of breath chromatograms revealed a mass ion as a biomarker that identified biopsy-proven lung cancer as well as suspicious pulmonary nodules on LDCT. The biomarker was termed Mass Abnormalities in Gaseous Ions with Imaging Correlates (MAGIIC). The chemical structure of MAGIIC was tentatively identified from the NIST library of mass spectra; the best-fit compounds included C4 and C5 alkane derivatives that were consistent with metabolic products of oxidative stress. Blinded validation of MAGIIC: the abundance of the MAGIIC biomarker was determined in a different group of 161 subjects undergoing screening with LDCT. They donated duplicate alveolar breath VOC samples that were analyzed at two independent laboratories. The study was blinded and monitored with Good Clinical Practice. The abundance of MAGIIC in breath predicted biopsy-proven lung cancer with 84% accuracy, sensitivity = 75.4% and specificity = 85.0%. MAGIIC also predicted pulmonary nodules in LDCT with 80.5% accuracy, sensitivity = 80.1% and specificity = 75.0%. Breath MAGIIC abundance was not significantly affected by tobacco smoking history. Conclusions: in a blinded study, breath VOC MAGIIC accurately predicted lung cancer confirmed on a tissue biopsy, as well as suspicious pulmonary nodules observed on LDCT. MAGIIC may have been a product of oxidative stress and it could potentially be employed as an ancillary to LDCT to predict the likelihood that a pulmonary nodule is malignant.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Volatile biomarkers of pulmonary tuberculosis in the breath
    Phillips, Michael
    Cataneo, Renee N.
    Condos, Rany
    Erickson, Gerald A. Ring
    Greenberg, Joel
    La Bombardi, Vincent
    Munawar, Muhammad I.
    Tietje, Olaf
    TUBERCULOSIS, 2007, 87 (01) : 44 - 52
  • [22] Pulmonary nodules measurements in CT lung cancer screening
    Heuvelmans, Marjolein A.
    Oudkerk, Matthijs
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2100 - S2102
  • [23] Preface on "pulmonary nodules special issue for lung cancer"
    Song, Yong
    Lv, Tangfeng
    Oudkerk, Matthijs
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (01) : 1 - 2
  • [24] Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
    Elena Kupert
    Marshall Anderson
    Yin Liu
    Paul Succop
    Linda Levin
    Jiang Wang
    Kathryn Wikenheiser-brokamp
    Pingping Chen
    Susan M Pinney
    Trudy Macdonald
    Zhongyun Dong
    Sandra Starnes
    Shan Lu
    BMC Cancer, 11
  • [25] The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules
    Shahram Tahvilian
    Joshua D. Kuban
    David F. Yankelevitz
    Daniel Leventon
    Claudia I. Henschke
    Jeffrey Zhu
    Lara Baden
    Rowena Yip
    Fred R. Hirsch
    Rebecca Reed
    Ashley Brown
    Allison Muldoon
    Michael Trejo
    Benjamin A. Katchman
    Michael J. Donovan
    Paul C. Pagano
    BMC Pulmonary Medicine, 23
  • [26] The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules
    Tahvilian, Shahram
    Kuban, Joshua D.
    Yankelevitz, David F.
    Leventon, Daniel
    Henschke, Claudia I.
    Zhu, Jeffrey
    Baden, Lara
    Yip, Rowena
    Hirsch, Fred R.
    Reed, Rebecca
    Brown, Ashley
    Muldoon, Allison
    Trejo, Michael
    Katchman, Benjamin A.
    Donovan, Michael J.
    Pagano, Paul C.
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [27] Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
    Kupert, Elena
    Anderson, Marshall
    Liu, Yin
    Succop, Paul
    Levin, Linda
    Wang, Jiang
    Wikenheiser-brokamp, Kathryn
    Chen, Pingping
    Pinney, Susan M.
    Macdonald, Trudy
    Dong, Zhongyun
    Starnes, Sandra
    Lu, Shan
    BMC CANCER, 2011, 11
  • [28] Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer
    Mazzone, Peter J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 774 - 780
  • [29] QUANTITATIVE BREATH ANALYSIS OF VOLATILE COMPOUNDS IN LUNG CANCER PATIENTS IN CHINA
    Xu, Guo-Bing
    Song, Geng
    Qin, Tao
    Liu, Hu
    Pan, Yue-Yin
    Xiong, Fu-Xing
    Gu, Kang-Sheng
    Sun, Guo-Ping
    Chen, Zhen-Dong
    DRUG METABOLISM REVIEWS, 2008, 40 : 53 - 54
  • [30] Progress in the Development of Volatile Exhaled Breath Signatures o Lung Cancer
    Mazzone, Peter J.
    Wang, Xiao-Feng
    Lim, Sung
    Jett, James
    Choi, Humberto
    Zhang, Qi
    Beukemann, Mary
    Seeley, Meredith
    Martino, Ray
    Rhodes, Paul
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (05) : 752 - 757